ArticleESC heart failure2025

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: a call to action from the cardio-kidney community.

Roberto Pecoits-Filho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.